Weight loss injections with no subscription: what to consider before you start

What 'no subscription' actually means for your treatment

The phrase gets used in two very different ways. Sometimes it means a service will not lock you into recurring payments or auto-renew your order without your active choice, that is a genuine patient benefit, and the right approach. Sometimes it is shorthand for minimal oversight: order today, same again next month, no one checks in. Those are not the same thing, and the difference matters clinically.

GLP-1 medicines work on a titration schedule. You begin at a low dose (2.5mg for tirzepatide, for example) and a prescriber increases it in steps as tolerability allows. How you are responding, whether your weight is changing, and whether any side effects have emerged are all relevant to the next dose decision. A service that dispatches without that re-check is not offering flexibility; it is cutting a corner that exists for a reason. If you are accessing treatment outside a GP setting, the online prescriber carries that clinical responsibility, and should be exercising it at every repeat.

At nume, there is no subscription and no auto-renewal. Every repeat order is individually re-reviewed by a GPhC-registered Independent Prescriber before anything is dispatched. You decide when to reorder, and a real clinician reads your answers before approving it. That structure is not a marketing position; it reflects how these medicines are meant to be used.

The safety factors a no-subscription service still needs to cover

No subscription does not mean no obligation. Any regulated private pharmacy dispensing Mounjaro or Wegovy (however its pricing is structured) must meet the same clinical standards. Those include verifying your identity, confirming your weight, checking your medical history, and carrying out a prescriber review before each supply. The licence conditions for these injections do not relax because the billing model is flexible.

Side effects are worth understanding before you start, and the NHS's guidance on tirzepatide is a good starting point. The most common effects are gastrointestinal (nausea, loose stools, constipation, reflux) and they tend to peak after starting or after a dose increase. For most people they settle within a couple of weeks. Knowing that pattern in advance means you are less likely to stop unnecessarily, and less likely to miss a symptom that warrants attention. A change in bowel habits after a dose increase, for instance, is common and usually short-lived; severe, persistent abdominal pain that radiates to the back is different and needs same-day medical attention, as the MHRA's January 2026 Drug Safety Update on GLP-1 medicines makes clear.

Support between orders matters too. At nume, aftercare is available seven days a week, not because you are locked into a plan, but because questions do not arrive on weekdays only. Payday cycles, bank holidays, a pen arriving just before a long weekend: timing your next order around real life is easier when you can reach someone who knows your case.

Cost context: what a transparent price should include

One of the more practical benefits of a no-subscription model is that costs are visible order by order. That makes it easier to compare services honestly, but worth knowing what a legitimate price should cover. Consultation fees, prescription fees, delivery charges and access to a prescriber for questions are all real costs that some headline prices exclude. A single transparent price that bundles all of those is usually better value than a low per-pen figure with fees on top, even if the headline looks higher. You can read more about how weight loss injection costs compare before making a decision.

For context: Eli Lilly raised Mounjaro's UK list price from 1 September 2025, with the highest-dose pen rising to around £330 per four-week pen; typical private prices since then have ranged roughly £149–£375 per month depending on dose and provider, as widely reported. Those figures give you a sense of the realistic market. Prices far below that range are a prompt to ask what is missing, clinical oversight included. The range of licensed options available varies by service too, so it is worth checking which medicines a pharmacy can actually prescribe for you.

nume's pricing, sorry. At nume, pricing is one transparent figure per order: it covers the consultation, prescription, treatment, and free next-working-day DPD delivery. No hidden fees. Because there is no subscription, you are never charged for a cycle you did not choose to start.

NHS access versus private: the honest picture

NHS access to these injections exists but is phased and criteria-based. NICE's appraisal of tirzepatide (TA1026) sets the threshold for NHS prescribing at BMI 35 or above with at least four qualifying conditions under the current phase, though this is broadening over time. Wegovy is available through specialist NHS weight management services under NICE TA875, but waiting lists are commonly long. For many people, private prescription is the realistic near-term route, and a no-subscription private service means you control the timing without an ongoing financial commitment when you are not actively ordering.

If you are thinking about whether private treatment is right for you, the weight loss treatment overview on our site covers both routes plainly. Our clinical team's approach is set out by our clinical lead, and our frequently asked questions cover the practical details most people ask about before starting. When you are ready to find out whether you are clinically eligible, a free consultation is the right next step, reviewed the same day by a prescriber, not a piece of software.